Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login
semaglutide online

Semaglutide: A Summary of Medications and FDA Warning for Compounding 

Share Post:

Did you know that Semaglutide, a medication known to regulate insulin, not only treats type 2 diabetes but also helps with weight loss? With three options endorsed by the Food and Drug Administration (FDA) – Ozempic and Wegovy as injectables, and Rybelsus as a tablet – they offer substantial benefits for both diabetes management and achieving weight loss goals.

Now, let’s see how Semaglutide works and check out its different versions. We’ll also talk about any important FDA warnings, giving you the important details that you need to know.

Mechanism of Action

Semaglutide replicates the natural release of the GLP-1 hormone in the gastrointestinal tract triggered by food consumption. The primary role of GLP-1 includes stimulating insulin production, reducing blood glucose levels, and influencing parts of the brain that control appetite and induce a sense of fullness. 

FDA-Approved Semaglutide Products

Semaglutide is available in three major products for treating diabetes and weight-related issues:

Ozempic: It is approved for diminishing blood glucose levels in people with type 2 diabetes. It is additionally authorized to alleviate the risk of heart attack and stroke. 

Wegovy: It is approved to assist adults and certain adolescents in weight loss, particularly those with obesity or excess weight and weight-related medical problems. It is meant to be used in conjunction with a controlled diet and regular exercise.

Rybelsus: It is approved for lowering blood sugar levels in type 2 diabetes patients, along with dietary and exercise measures.

Compounding of Semaglutide

In situations where a particular drug like Semaglutide faces a shortage, pharmacies are authorized to create custom versions. However, it is essential to note that compounded drugs, which involve altering or combining existing medications, including those containing Semaglutide, bypass the rigorous oversight of the FDA. 

Concerns with Compounded Semaglutide

The Food and Drug Administration (FDA) expressed increased concerns about compounded Semaglutide, particularly those incorporating different salt forms than the base Semaglutide used in approved drugs. These concerns led the FDA to strongly advise against using such formulations.

FDA Warnings and Actions

In response to emerging concerns, the FDA has consistently issued warnings against the utilization of compounded Semaglutide medications. The agency’s apprehensions revolve around the incorporation of salt forms in compounded products, contributing to chemical disparities from the FDA-approved Semaglutide.

Patient and Professional Guidance

Patients are urged to obtain Semaglutide products only with a prescription from licensed healthcare providers and state-licensed pharmacies or FDA-registered outsourcing facilities. Healthcare professionals are instructed to exercise caution when considering compounded Semaglutide and be aware of the potential use of salt forms by compounders.  

Profile image of CDI Staff Writer

Written by CDI Staff Writer on February 17, 2024

Related Products

Related Articles

Diabetes, Weight Loss
GLP-1 Receptor Agonists: A New Frontier in Combating Cocaine Addiction

Summary: Discover how GLP-1 receptor agonists are emerging as a potential treatment for cocaine addiction, offering hope for effective intervention.Cocaine addiction remains a significant public health issue, with limited effective…

Read More
Diabetes, Diabetes Supplies,
Metformin: A Promising Non-Invasive Therapy for Geographic Atrophy in Age-Related Macular Degeneration

Summary: Metformin, a commonly used medication for diabetes, shows promise as a non-invasive treatment for geographic atrophy (GA), a severe form of age-related macular degeneration (AMD). Recent studies suggest metformin…

Read More
Diabetes, Type 2
Semaglutide Shows Promise in Smoking Cessation for Patients with Type 2 Diabetes

Summary: Semaglutide shows promise in helping patients with type 2 diabetes quit smoking. A study found it reduced tobacco use disorder-related medical visits and the need for smoking cessation medications.…

Read More
Diabetes, Diabetes Supplies,
When Will Retatrutide Be Available? Insights into the Future of Diabetes and Obesity Care

Summary: Retatrutide is an innovative weight loss medication in Phase 3 trials, designed to target three key hormones to aid in weight loss and improve metabolic health. With its unique…

Read More